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ABSTRACT 
INTRODUCTION: 
Bladder cancer currently occupies eighth place, 90% being urothelial 
neoplasms. Current clinical and pathological variables have limited ability to 
predict tumor recurrence and progression.With availability of  effective  
chemotherapy there is need for accurate predictors.Ki 67 is expressed by 
proliferating cells and can be observed immunohistochemically. Nuclear Ki 67 
antigen expression is a measure of cell growth fraction and hence measures 
biological aggressiveness of malignancy. 
AIMS: 
  To determine correlation of clinicopathological characteristics and Ki 67 
expression with tumour grading and staging,thereby its impact on prognosis and 
clinical outcome. 
METHODS: 
         This is a prospective study undertaken for a period of 1year. Clinical details 
of 30 bladder carcinoma patients were recorded and their TURBT specimens 
received are subjected to histopathological and immunohistochemical study. Ki 67 
scoring was done and compared with grading and staging. 
RESULTS:  
A total of 77% of the patients presented with painless hematuria.The mean 
age was 64 ± 4 years old and the male to female ratio was 5:1.  A total of 63% of 
the patients had muscle invasive disease at the time of presentation.  Overall 33% 
(10 0f 30) of the patients had low-grade disease and 67% (20 of 30) had high grade 
tumors. The analysis of   Ki 67 expression immunohistochemically revealed, 
higher values (i.e 3+ and 4+) in high grade tumors and t2 stage tumors. 
CONCLUSION: 
Proliferative activity of urothelial neoplasms assessed by Ki 67 expression 
correlated well with tumor grading and staging. Therefore it indicates prognosis 
and clinical outcome of patients. 
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